These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12798515)

  • 1. Recombinant activated factor VII: a new weapon in the fight against hemorrhage.
    Branch DW; Rodgers GM
    Obstet Gynecol; 2003 Jun; 101(6):1155-6. PubMed ID: 12798515
    [No Abstract]   [Full Text] [Related]  

  • 2. Recombinant factor VIIa and trauma: treatment that does not leave you in the cold.
    Levi M
    J Thromb Haemost; 2007 Feb; 5(2):242-3. PubMed ID: 17181827
    [No Abstract]   [Full Text] [Related]  

  • 3. Activated prothrombin complex concentrates and recombinant factor VIIa in the bleeding patient: are they appropriate and safe?
    Aledort LM
    J Thorac Cardiovasc Surg; 2003 Dec; 126(6):2112-3. PubMed ID: 14688750
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant activated factor VII in cardiac surgery: a systematic review.
    Warren O; Mandal K; Hadjianastassiou V; Knowlton L; Panesar S; John K; Darzi A; Athanasiou T
    Ann Thorac Surg; 2007 Feb; 83(2):707-14. PubMed ID: 17258029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rFVIIa (Novoseven): the new panacea?
    Ickx BE
    Acta Anaesthesiol Belg; 2003; 54(4):333-5. PubMed ID: 14719355
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant factor VIIa in massive postpartum haemorrhage.
    Karalapillai D; Popham P
    Int J Obstet Anesth; 2007 Jan; 16(1):29-34. PubMed ID: 17125989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Place of recombinant activated factor VII in the treatment of severe haemorrhage in paediatric patients].
    Veyckemans F
    Ann Fr Anesth Reanim; 2009; 28(7-8):676-7. PubMed ID: 19574019
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro/con debate: does recombinant factor VIIa have a role to play in the treatment of patients with acute nontraumatic hemorrhage?
    Pieri P; Stein DM; Scarpelini S; Rizoli S
    Crit Care; 2006; 10(3):214. PubMed ID: 16762042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recombinant activated factor VII to control bleeding in cardiovascular surgery: need of efficacy and safety validation].
    Blanloeil Y; Rigal JC; Bastien O; Carteau JP; Toussaint-Hacquard M; Lecompte T
    Ann Fr Anesth Reanim; 2006 Jan; 25(1):2-5. PubMed ID: 16377121
    [No Abstract]   [Full Text] [Related]  

  • 10. Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
    Spahn DR; Tucci MA; Makris M
    Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804
    [No Abstract]   [Full Text] [Related]  

  • 11. Recombinant activated factor VII: panacea or passing fad?
    Parker RI
    Pediatr Crit Care Med; 2005 May; 6(3):379-80. PubMed ID: 15880015
    [No Abstract]   [Full Text] [Related]  

  • 12. Off-label use of recombinant factor VIIA concentrates after cardiac surgery.
    Despotis G; Avidan M; Lublin DM
    Ann Thorac Surg; 2005 Jul; 80(1):3-5. PubMed ID: 15975330
    [No Abstract]   [Full Text] [Related]  

  • 13. A response to 'the use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Geoghegan J; Tasker L
    Anaesthesia; 2005 Nov; 60(11):1156-7; author reply 1157. PubMed ID: 16229713
    [No Abstract]   [Full Text] [Related]  

  • 14. The safety of recombinant factor VIIa: a rebuttal.
    Teitel J; Poon MC
    J Thromb Haemost; 2004 Nov; 2(11):2078; author reply 2079. PubMed ID: 15550060
    [No Abstract]   [Full Text] [Related]  

  • 15. [Recombinant factor VII in the treatment of acute hemorrhage due to esophageal varices].
    Jiménez-Sáenz M; Romero-Castro R
    Gastroenterol Hepatol; 2005; 28(6):333-6. PubMed ID: 15989815
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
    Cruz-Flores S
    Neurology; 2007 May; 68(20):1750-1; author reply 1751. PubMed ID: 17502566
    [No Abstract]   [Full Text] [Related]  

  • 17. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant activated factor VII (NovoSeven) stops severe intra-abdominal bleeding after liver needle biopsy without surgery.
    Sendensky A; Gutzwiller JP; Schneider-Frost J; Wuillemin WA; Graeni R; Beglinger C
    Blood Coagul Fibrinolysis; 2004 Oct; 15(8):701-2. PubMed ID: 15613927
    [No Abstract]   [Full Text] [Related]  

  • 19. Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.
    Guillet B; Pinganaud C; Proulle V; Dreyfus M; Lambert T
    Thromb Haemost; 2002 Oct; 88(4):698-9. PubMed ID: 12362252
    [No Abstract]   [Full Text] [Related]  

  • 20. Preemptive use of recombinant activated factor VII: many questions but few answers.
    Samama CM
    Can J Anaesth; 2006 Apr; 53(4):336-8. PubMed ID: 16575029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.